Home / Resource Library / QUALITY OF LIFE (QOL) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES RECEIVING RITUXIMAB BIOSIMILARS: RESULTS FROM A REAL-WORLD SETTING
QUALITY OF LIFE (QOL) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES RECEIVING RITUXIMAB BIOSIMILARS: RESULTS FROM A REAL-WORLD SETTING